”Asahi Kasei Pharma open innovation” is an innovation platform started in 2016 in Japan to recruit candidates for research collaborations related to drug discovery. They are publicly calling for new proposals related to drug development research to promote pharmaceutical research and development through enhanced cooperation around the world.
The selected candidates receive collaborative research opportunities, with research funding and contribution to the program through Asahi Kasei Pharma scientists’ research activities. If successful, separate license agreements that include payments such as upfront, milestones, and royalties are offered.
Proposals are solicited in relation to new drug candidates and technologies in the therapeutic fields of chronic pain/neurodegenerative disease, autoimmune disease, critical care medicine, and bone/cartilage conditions, muscle-related disease, and platform technologies for drug discovery such as pharmacokinetics and pharmaceutical formulation. Submissions will be assessed with respect to their potential as concepts for collaborative research and fostering of research.
Professional drug discovery research candidates can apply from January 7 to February 26, 2020.